Medicine and Dentistry
Adiponectin
45%
Adipose Derived Stem Cell
45%
Adipose Tissue
27%
Adverse Event
9%
Angina Pectoris
9%
Aptitude
18%
Association
13%
Attention
9%
Bone Marrow Derived Mesenchymal Stem Cell
9%
Cell Composition
9%
Cell Growth
18%
Cells
45%
Chronic Total Occlusion
45%
Cohort Analysis
9%
Combination Therapy
45%
Complication
18%
Coronary Angiography
45%
Coronary Computed Tomography Angiography
45%
Coronary Occlusion
45%
Culture
9%
Differentiation
9%
Docosahexaenoic Acid
13%
Donor
9%
Enzyme
18%
Fetal Calf Serum
9%
Follow up
56%
Granulocyte
18%
Heart Failure
18%
Heart Muscle Ischemia
9%
Icosapentaenoic Acid
18%
Inpatient
100%
Ischemic Heart Disease
20%
Lesion
48%
Lipid
45%
Lipoprotein
45%
Myocardial Infarction
12%
New York Heart Association Class
9%
Omega-3 Fatty Acid
45%
Patient
80%
Percutaneous Coronary Intervention
72%
Plasma
45%
Platelet
13%
Precursor
9%
Rapamycin
45%
Serum
59%
Stem Cell
18%
Stent
45%
Therapeutic Procedure
56%
Tissue Engineering
45%
Vasodilatation
45%
Biochemistry, Genetics and Molecular Biology
Adiponectin
45%
Blood Lipids
45%
Docosahexaenoic Acid
13%
Eicosapentaenoic Acid
18%
Flow
45%
Lipoprotein Blood Level
45%
Omega 3 Fatty Acid
45%
Platelet
13%
Polyunsaturated Fatty Acid
13%
Triacylglycerol Blood Level
8%
Triglyceride-Rich Lipoprotein
8%
Vasodilatation
45%
Pharmacology, Toxicology and Pharmaceutical Science
Adiponectin
45%
CD34 Antibody
45%
Clinical Trial
18%
Docosahexaenoic Acid
13%
Enzyme
18%
Heart Failure
9%
Heart Infarction
12%
Icosapentaenoic Acid
18%
Ischemic Heart Disease
19%
Omega-3 Fatty Acid
45%
Pharmacotherapy
6%
Sirolimus
45%
